Literature DB >> 27407813

Nesiritide - A New Agent For Acute Decompensated Heart Failure.

A G Mathur1, J K Kairi2, B B Nayak3.   

Abstract

Keywords:  Decompensated Heart Failure; Nesiritide

Year:  2011        PMID： 27407813      PMCID： PMC4922929          DOI： 10.1016/S0377-1237(05)80072-3

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN： 0377-1237


× No keyword cloud information.
  8 in total

1.  The use of nesiritide in the management of acute decompensated heart failure.

Authors:  Steven R Kayser
Journal:  Prog Cardiovasc Nurs       Date:  2002

2.  B-type natriuretic peptide -- a window to the heart.

Authors:  Kenneth L Baughman
Journal:  N Engl J Med       Date:  2002-07-18       Impact factor: 91.245

3.  Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study.

Authors:  Andrew J Burger; Darlene P Horton; Thierry LeJemtel; Jalal K Ghali; Guillermo Torre; George Dennish; Michael Koren; Jay Dinerman; Marc Silver; Mei L Cheng; Uri Elkayam
Journal:  Am Heart J       Date:  2002-12       Impact factor: 4.749

4.  Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial.

Authors:  Michael S Cuffe; Robert M Califf; Kirkwood F Adams; Raymond Benza; Robert Bourge; Wilson S Colucci; Barry M Massie; Christopher M O'Connor; Ileana Pina; Rebecca Quigg; Marc A Silver; Mihai Gheorghiade
Journal:  JAMA       Date:  2002-03-27       Impact factor: 56.272

5.  Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial.

Authors: 
Journal:  JAMA       Date:  2002-03-27       Impact factor: 56.272

Review 6.  Safety and efficacy of nesiritide for the treatment of decompensated heart failure.

Authors:  Charles L Emerman
Journal:  Rev Cardiovasc Med       Date:  2002       Impact factor: 2.930

7.  Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group.

Authors:  W S Colucci; U Elkayam; D P Horton; W T Abraham; R C Bourge; A D Johnson; L E Wagoner; M M Givertz; C S Liang; M Neibaur; W H Haught; T H LeJemtel
Journal:  N Engl J Med       Date:  2000-07-27       Impact factor: 91.245

Review 8.  The evolving role of nesiritide in advanced or decompensated heart failure.

Authors:  Issam Zineh; Richard S Schofield; Julie A Johnson
Journal:  Pharmacotherapy       Date:  2003-10       Impact factor: 4.705
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.